Was the government right to reject "Jimmy the Juice Man Peachy Strawberry,” “Killer Kustard,” and “Iced Pineapple Express"?

The Supreme Court is scheduled Monday to consider the regulation of flavored e-cigarettes in a case that illustrates an ...

If there's one thing to target during Bonobos' Black Friday sale, it's a pair of its bestselling chinos, which are selling for one of the lowest prices we've ever seen. Select colors of the ...

With no prior experience in the eyewear industry, Eyewa started by selling eyewear brands, including Ray-Ban, Gucci, Prada, and Johnson & Johnson, online for two years. By then, it had enough data ...

Lucky for you, Aldi is selling a gorgeous 5-wick candle this coming week that is not only pretty big but also affordable. Plus it looks like styles from Pottery Barn and Crate & Barrel that are ...

Nintendo's Switch might be nipping at its heels, but PlayStation 2 continues to hold the record as the best-selling console of all time - with Sony now confirming the machine has shifted a ...

Below is a list of the "literal" best-selling shows by category. Pro tip: Shows play in small, medium, and large Broadway theaters that physically hold different amounts of patrons. Consider that ...

India is a marketplace booming with smartphones duking it out on various price points. From the killer-budget phones to the ultra-flagships, there is a phone for everyone. Of course, the market ...

SALT LAKE CITY (ABC4) — A Salt Lake City man has been formally charged on a charge of forcible sexual abuse after he reportedly inappropriately touched a woman while driving her home from a concert.

HONOLULU (KHON2) — Ocean Safety Bureau officials have posted Box Jellyfish warning signs at Salt Pond Beach Park, advising beachgoers to avoid swimming in the area. Download the free KHON2 app for iOS ...

Bacon sandwiches, chorizo cake and beer are off the menu if you want to cut your risk of cancer, according to Matthew Lambert, nutritionist and Health Information and Promotion Manager at World ...

Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual revenue in 2023, earning $22.2 billion by 2025, according to new research by GlobalData.